Personalizing esketamine treatment in TRD and TRBD
The role of mentalization, cognitive rigidity, psychache, and suicidality
Bibliographic Data
These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals with treatment-resistant depressive episode patients
Cognition · Cognitive bias · Depression (economics · Depressive symptoms · Major depressive disorder · Treatment-resistant depression · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Mental Health Research Topics · Treatment of Major Depression
Development and preliminary validation of a scale of psychache.
Development and Validation of a Self-Report Measure of Mentalizing
The Columbia–Suicide Severity Rating Scale
Resistance to change
A New Depression Scale Designed to be Sensitive to Change
Demystifying cognitive flexibility
Reconsidering anhedonia in depression
The “Reading the Mind in the Eyes” Test Revised Version
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |